Subsequent studies revealed BIN-1 to interfere with malignant transformation utilizing several mechanisms beyond the suppression of MYC activity and additional work showed BIN-1 to play the role of a tumor suppressor in several cancer types including melanoma, breast cancer, colon cancer, and prostate cancer (31–33). Here, BIN1 is linked to prostate carcinoma.